Tandem Diabetes Care Inc. (TNDM)
$14.11
$-0.58
(-3.95%)
As on 13-May-2026 16:17EDT
Market cap
$1,012 Mln
Revenue (TTM)
$1,028 Mln
P/E Ratio
--
P/B Ratio
8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.7 %
-
ROCE
-- %
-
Industry P/E
44.07
-
EV/EBITDA
345.7
-
Debt to Equity
4.5
-
Book Value
$--
-
EPS
$-1.4
-
Face value
--
-
Shares outstanding
68,529,089
10 Years Aggregate
CFO
$-59.18 Mln
EBITDA
$-437.40 Mln
Net Profit
$-791.81 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
| -35.8 | -26.4 | -24.5 | -38.6 | -24.6 | -29.3 | -14.7 |
|
BSE Sensex*
| -10.9 | -1.9 | -8.7 | -7.1 | 6.7 | 9.1 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
| -39.0 | 21.6 | -34.2 | -70.1 | 57.3 | 60.5 | 57.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tandem Diabetes Care (TNDM)
|
14.1 | 1,012.2 | 1,027.5 | -94.6 | -7.0 | -71.3 | -- | 8.0 |
| 7.9 | 5,441.6 | 6,552.2 | -551.4 | -4.3 | -9.9 | -- | 1.0 | |
| 255.5 | 6,838.7 | 2,589.9 | 168.8 | 21.4 | 2.5 | 42.5 | 1.0 | |
| 43.9 | 6,586.8 | 3,458.5 | -10.3 | 1.9 | -0.5 | -- | 2.7 | |
| 23.9 | 3,938.0 | 2,808.1 | 67.7 | 6.8 | 2.2 | 59 | 1.3 | |
| 137.3 | 7,950.8 | 551.4 | -189.3 | -15.6 | -26.3 | -- | 11.7 | |
| 96.5 | 6,124.5 | 1,546.2 | 279.0 | 15.0 | 23.9 | 22.5 | 5.0 | |
| 178.4 | 9,347.9 | 1,558.5 | 76.3 | 19.1 | 9.5 | 44.1 | 11.8 | |
| 322.6 | 12,653.3 | 1,454.3 | 171.1 | 11.1 | 12.1 | 74.1 | 8.6 | |
| 107.0 | 6,538.2 | 763.3 | 51.4 | 11.6 | 2.5 | 127.4 | 3.3 |
Shareholding Pattern
View DetailsAbout Tandem Diabetes Care (TNDM)
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin... pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Address: 12400 High Bluff Drive, San Diego, CA, United States, 92130 Read more
-
President, CEO & Director
Mr. John F. Sheridan
-
President, CEO & Director
Mr. John F. Sheridan
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Tandem Diabetes Care (TNDM)
What is the current share price of Tandem Diabetes Care Inc (TNDM) Today?
The share price of Tandem Diabetes Care Inc (TNDM) is $14.11 (NASDAQ) as of 13-May-2026 16:17 EDT. Tandem Diabetes Care Inc (TNDM) has given a return of -24.63% in the last 3 years.
What is the current PB & PE ratio of Tandem Diabetes Care Inc (TNDM)?
Since, TTM earnings of Tandem Diabetes Care Inc (TNDM) is negative, P/E ratio is not available.
The P/B ratio of Tandem Diabetes Care Inc (TNDM) is 8.01 times as on 12-May-2026, a 177 premium to its peers’ median range of 2.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-7.30
|
9.63
|
|
2024
|
-24.82
|
9.06
|
|
2023
|
-8.69
|
6.17
|
|
2022
|
-30.59
|
6.58
|
|
2021
|
637.50
|
22.91
|
What is the 52 Week High and Low of Tandem Diabetes Care Inc (TNDM)?
The 52-week high and low of Tandem Diabetes Care Inc (TNDM) are Rs 29.65 and Rs 9.98 as of 14-May-2026.
What is the market cap of Tandem Diabetes Care Inc (TNDM)?
Tandem Diabetes Care Inc (TNDM) has a market capitalisation of $ 1,012 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Tandem Diabetes Care Inc (TNDM)?
Before investing in Tandem Diabetes Care Inc (TNDM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.